FDA Allows ‘May Reduce Risk of Type 2 Diabetes’ Claim on Yogurt Labels

The FDA approved the claim, reversing previous denial and despite some evidence flaws.

Paul J. Richards/AFP via Getty Images

The U.S. Food and Drug Administration has approved the claim that yogurt may reduce the risk of type 2 diabetes, reversing its previous denial of a request from Danone North America, the largest U.S. yogurt manufacturer.

In 2019, Danone had petitioned for a qualified health claim linking regular yogurt consumption to a lower diabetes risk, but the FDA initially concluded there was limited supporting evidence.